Paige Secures Financing from KKR for Total Series C Funding Round of Over $125 Million

11 Mar, 2021

Paige Secures Financing from KKR for Total Series C Funding Round of Over $125 Million
Photo by Mike Kononov on Unsplash

– Paige, a global leader in AI-based diagnostic software in pathology, today announced that KKR, a leading global investment firm, joined Casdin Capital and Johnson & Johnson Innovation – JJDC, Inc. (JJDC) as co-leads in its Series C financing round, bringing the round to over $125 million.
– Paige will use this new capital to expand its geographic footprint as it accelerates the development of AI-based clinical applications, biomarkers and diagnostics.
– Additional investors in the Series C round include Catalio Capital Management, existing investors and other funds, as previously announced.
– For KKR, the investment is being funded through the firm’s Health Care Strategic Growth Fund, which is focused on investing in high-growth health care-related companies for which KKR can be a unique partner in helping reach scale.

Artificial Intelligence Biopharma Health Care Health Diagnostics North America Software
Crunchbase icon

Content report

The following text will be sent to our editors: